UQ research finds molecular doorways to help deliver drugs into the brain

FHS
May 2, 2024
2:42 pm

A University of Queensland researcher has found molecular doorways that could be used to help deliver drugs into the brain to treat neurological disorders.

Mecbotamab vedotin by BioAtla for Breast Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 24, 2023

Alzheimer’s Trials Fail; Blood Test Predicts Tau; Neuroscience Moves to Bluesky

Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer’s disease patients in the ReThink-ALZ phase III trial, Cassava Sciences reported. The company stopped

November 27, 2024

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.